Histology-Based Radiomics for [18F]FDG PET Identifies Tissue Heterogeneity in Pancreatic Cancer
- PMID: 38782455
- DOI: 10.2967/jnumed.123.266262
Histology-Based Radiomics for [18F]FDG PET Identifies Tissue Heterogeneity in Pancreatic Cancer
Abstract
Radiomics features can reveal hidden patterns in a tumor but usually lack an underlying biologic rationale. In this work, we aimed to investigate whether there is a correlation between radiomics features extracted from [18F]FDG PET images and histologic expression patterns of a glycolytic marker, monocarboxylate transporter-4 (MCT4), in pancreatic cancer. Methods: A cohort of pancreatic ductal adenocarcinoma patients (n = 29) for whom both tumor cross sections and [18F]FDG PET/CT scans were available was used to develop an [18F]FDG PET radiomics signature. By using immunohistochemistry for MCT4, we computed density maps of MCT4 expression and extracted pathomics features. Cluster analysis identified 2 subgroups with distinct MCT4 expression patterns. From corresponding [18F]FDG PET scans, radiomics features that associate with the predefined MCT4 subgroups were identified. Results: Complex heat map visualization showed that the MCT4-high/heterogeneous subgroup was correlating with a higher MCT4 expression level and local variation. This pattern linked to a specific [18F]FDG PET signature, characterized by a higher SUVmean and SUVmax and second-order radiomics features, correlating with local variation. This MCT4-based [18F]FDG PET signature of 7 radiomics features demonstrated prognostic value in an independent cohort of pancreatic cancer patients (n = 71) and identified patients with worse survival. Conclusion: Our cross-modal pipeline allows the development of PET scan signatures based on immunohistochemical analysis of markers of a particular biologic feature, here demonstrated on pancreatic cancer using intratumoral MCT4 expression levels to select [18F]FDG PET radiomics features. This study demonstrated the potential of radiomics scores to noninvasively capture intratumoral marker heterogeneity and identify a subset of pancreatic ductal adenocarcinoma patients with a poor prognosis.
Keywords: [18F]FDG PET; immunohistochemistry; machine learning; pancreatic cancer; tumor metabolism.
© 2024 by the Society of Nuclear Medicine and Molecular Imaging.
Similar articles
-
2-[18F]FDG PET-based quantification of lymph node metabolic heterogeneity for predicting lymph node metastasis in patients with colorectal cancer.Eur J Nucl Med Mol Imaging. 2024 May;51(6):1729-1740. doi: 10.1007/s00259-023-06578-6. Epub 2023 Dec 27. Eur J Nucl Med Mol Imaging. 2024. PMID: 38150017
-
A multidomain fusion model of radiomics and deep learning to discriminate between PDAC and AIP based on 18F-FDG PET/CT images.Jpn J Radiol. 2023 Apr;41(4):417-427. doi: 10.1007/s11604-022-01363-1. Epub 2022 Nov 21. Jpn J Radiol. 2023. PMID: 36409398 Free PMC article.
-
A review on advances in 18F-FDG PET/CT radiomics standardisation and application in lung disease management.Insights Imaging. 2022 Feb 5;13(1):22. doi: 10.1186/s13244-021-01153-9. Insights Imaging. 2022. PMID: 35124733 Free PMC article. Review.
-
Preoperative prediction of pathological grade in pancreatic ductal adenocarcinoma based on 18F-FDG PET/CT radiomics.EJNMMI Res. 2021 Feb 25;11(1):19. doi: 10.1186/s13550-021-00760-3. EJNMMI Res. 2021. PMID: 33630176 Free PMC article.
-
Radiomics analysis for the differentiation of autoimmune pancreatitis and pancreatic ductal adenocarcinoma in 18 F-FDG PET/CT.Med Phys. 2019 Oct;46(10):4520-4530. doi: 10.1002/mp.13733. Epub 2019 Aug 13. Med Phys. 2019. PMID: 31348535
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical